Message from Chairman & Managing Director
I bring warm greetings from apex.
The last 4 decades have been an immensely gratifying experience with apex laboratories. With very humble beginnings, today apex is a significant player in the Indian pharmaceutical industry. We have evolved as a value based organization, with focus on quality products, 100% ethical promotion, strong people base and customer focus and we have established our leadership in the market by leveraging these strengths.
With one third of the products in the world market being manufactured in the country, the Indian pharmaceutical industry is poised for exponential growth and immense opportunities.
Our company's ambitious plans for the future will be fuelled by the 4 growth engines namely - leveraging its manufacturing strength, increased presence in overseas markets including regulated markets, new product launches and increased focus on R & D for innovation.
Our successful marketing track record should make us an attractive proposition for multinational pharma companies looking to introduce their products in India.
The company has set up modern manufacturing facilities conforming to cGMP norms and international standards to provide exclusive production facilities and increased capacity to manufacture oral liquids, oral solids and topicals, apart from giving us the additional capacity to undertake contract manufacturing. These units are built to international specifications and will be able to produce and supply products to the global market in addition to our existing presence in Asia and Africa and some regulated countries like UK, Europe and Canada.
With renewed and strategic focus on R & D, the company aims to develop many innovative products for the global market. The excusive, DSIR - approved facility has qualified scientists and the team has developed and obtained patent for nearly100 products.
Leveraging our innate strength and with the new initiatives, I am sure we will achieve its short term and long term business goals to be among the global leaders in pharmaceutical space in the foreseeable future.
Chairman & Managing Director.